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Figure 3. Correlation between the number o f CDl lb  mole­
cules present on unstimulated peripheral blood PMN and the 
increased number that is present on these PMN after in vitro 
stimulation with LTB4>
considerably. However, in contrast to the difference with res­
pect to absolute values, the relative C D llb  up-regulation was 
virtually identical in patients and healthy subjects. 
Experimental variability of flow cytometrical C Dllb assess­
ment proved to be below 10% comparing the triplicate mea­
surements. Therefore, the present investigation reconfirms the 
high experimental reproducibility of the methods used.
In patients and healthy volunteers, the C D llb-levels on 
peripheral blood PMN following stimulation with LTB4 corre­
late with the basal levels of CDllb, as illustrated in Figure 3. 
Therefore, unstimulated PMN CDllb expression determines 
LTB4-induced PMN CDllb expression. The correlation bet­
ween unstimulated and stimulated CDllb-levels in psoriatic 
patients and healthy controls seems to be comparable since 
there is no difference in relative CD1 lb up-regulation between 
both groups. This provides a strong indication that the signal­
ling from LTB4-receptor binding up to CDllb expression on 
peripheral blood PfylN is essentially normal in psoriasis.
The tendency to decreased basal expression of CDl lb and 
the significantly decreased LTB4-induced psoriatic PMN 
CDllb expression compared to normal PMN indicates a 
decreased number of CD1 lb-hemireceptors on psoriatic 
PMN. The decreased expression of CDl lb  on peripheral 
blood PMN, further decreasing in unstable psoriasis, is in 
sharp contrast with the in vitro chemotaxis and protease acti­
vity which increases in unstable psoriasis [8].
Three explanations for the decreased CDl lb expression of 
circulating psoriatic PMN may be hypothesized: (1) compart- 
mentalisation of PMN subpopulations; (2) habituation to 
increased levels of leukotriene B4; (3) active down-modula- 
tion of CD1 lb-levels on psoriatic peripheral blood PMN.
The hypothesis of compartmentalisation of circulating blood 
PMN is based on PMN subset selection. It is probable that 
the PMN-subpopulation with the highest CD1 lb expression is 
most likely to be recruited to invade the inflammed psoriatic 
skin, whereas PMN with a more modest density of CDllb  
remain in the blood circulation. Indeed, patients with unstable 
psoriasis proved to have an even lower CDllb expression on 
peripheral blood PMN than the overall group of psoriatic 
patients, In active psoriatic lesions, PMN-influx has been 
reported in 78% of patients and in chronic plaque lesions, 
PMN-influx proved to occur in 41% of patients [27].
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An alternative explanation is habituation of peripheral blood 
PMN to increased LTB4~levels present in psoriatic skin. This 
hypothesis is supported by the observation that in psoriatic 
uninvolved skin a decreased accumulation of PMN occurs 
following a standardized stimulus with LTB4 [28, 29]. Repea­
ted LTB4 applications resulted in a decreased PMN accumu­
lation as compared to the response following a single applica­
tion [29]. However, in view of the fact that the relative 
CDl lb  up-regulation by LTB4 in psoriatics proved to be 
essentially normal, this hypothesis is not supported by the 
observations in the present study.
Active down-modulation of C D l l b  is another possible 
mechanism that could explain the decreased PMN CDl lb  
expression in psoriatic patients. It may be possible that such a 
defence mechanism exists in order to prevent massive cuta­
neous damage due to the abundant skin presence of PMN. To 
the best of our knowledge there are no known active down- 
modulators of CDl lb.  However, integrin a-units, like CDllb  
need divalent cations (calcium or magnesium) for their adhe­
sive functions, and receptor function can be rapidly modula­
ted through phosphorylation reactions [9], It might well be 
possible that CDl lb  can be down-modulated on a functional 
level by changes in cation-concentrations and phosphorylase 
activity.
Since LTB4-induced signalling in psoriatic PMN is essentially 
normal, the question arises as to what extent LTB4 is relevant 
to the CDl lb up-regulation of psoriatic PMN in vivo. The 
role of LTB4 in psoriasis has been challenged further by the 
modest effects of 5-lipoxygenase inhibitors in the treatment 
of psoriasis [30-33].
The decreased CDl lb  expression on peripheral blood PMN in 
psoriasis remains an intriguing finding, and further studies 
should be aimed at mediators and factors involved in PMN 
compartmentalisation in psoriasis, and at mechanisms invol­
ved in the in vivo regulation of CD1 lb in psoriatic patients. ■
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